药物递送过程模拟-量化帕克利塔塞尔和克雷莫福尔EL的构造动态
1Alberta Computational Biochemistry Lab, Edmonton, Alberta, Canada.
PloS one
|May 12, 2025
概括
这项研究揭示了帕克利塔克塞尔和克雷莫EL如何形成菌体,使药物度高而没有聚合. 分子动力学模拟量化它们的相互作用和能量状态,以改善癌症药物递送系统.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
- 材料科学 材料科学 材料科学
背景情况:
- 帕克利塔克塞尔是一种关键的抗瘤药物,其第一个输送系统使用了cremophor EL和乙醇 (Taxol micelle).
- 之前的研究缺乏详细的分子动力学分析Taxol小细胞内的帕克利塔塞尔-克雷莫EL相互作用.
- 了解这些相互作用对于优化药物输送和疗效至关重要.
研究的目的:
- 使用分子动力学量化Taxol菌株中帕克利塔塞尔和克雷莫福EL的结构和构造性质.
- 分析了cremophor EL网络的自组装和药物加载能力.
- 建立分子构造,能量状态和小细胞稳定性之间的相关性.
主要方法:
- 使用全原子和粗粒度方法进行系统的分子模拟.
- 对帕克利塔塞尔和克雷莫福尔EL形状和能量状态的统计分析.
- 在cremophor EL网络中调查帕克利塔塞尔吸附/脱附动态.
主要成果:
- 克雷莫福尔EL形成了一个3D聚类网络,可以在没有聚合的情况下促进高帕克利塔塞尔负载.
- 由于吸附/脱吸,帕克利塔塞尔在克雷莫EL腔内表现出振荡行为.
- 最低能量的帕克利塔塞尔构造涉及核心附近的侧链环;在最低能量的情况下,cremophor EL采用螺旋形状,闭翼.
结论:
- 确立了帕克利塔克塞尔-克雷莫EL小粒体的分子构造和能量状态之间的可靠统计相关性.
- 开发的建模方法为分析药物输送系统和设计新药配方提供了一个框架.
- 这项研究提高了对Taxol菌根结构和功能的理解,为改进的癌症治疗铺平了道路.
相关概念视频
01:20Compartment Models: Two-Compartment Model
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
01:18Pharmacodynamic Models: Emax Drug–Concentration Effect Model
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...